Manning Anthony M.
SEC Form 4 insider trading activity
Manning Anthony M. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Manning Anthony M. is listed as Director at Monte Rosa Therapeutics, Inc. Inside the rolling window, Manning Anthony M. reported no open-market purchases and 2 open-market sales totaling $411K in GLUE. The largest disclosed transaction in the window is a sale of 10,000 GLUE shares on Jun 29, 2026, worth $231K.
Companies traded
Other insiders at GLUE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$411K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Manning Anthony M. made?
Manning Anthony M. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Manning Anthony M. trade?
Manning Anthony M. has filed SEC Form 4 disclosures for 1 company, including GLUE.
When was Manning Anthony M.'s most recent SEC Form 4 filing?
Manning Anthony M.'s most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Manning Anthony M.'s total buy and sell value in the current window?
Inside the rolling retention window, Manning Anthony M. bought $0 and sold $411K based on SEC Form 4 filings.
What was Manning Anthony M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 GLUE shares on 2026-06-29, worth $231K, per SEC Form 4 filings.